NO954146L - Belagte farmasöytiske preparater - Google Patents

Belagte farmasöytiske preparater

Info

Publication number
NO954146L
NO954146L NO954146A NO954146A NO954146L NO 954146 L NO954146 L NO 954146L NO 954146 A NO954146 A NO 954146A NO 954146 A NO954146 A NO 954146A NO 954146 L NO954146 L NO 954146L
Authority
NO
Norway
Prior art keywords
composition
pharmaceutical preparations
coated pharmaceutical
carboxamides
coated
Prior art date
Application number
NO954146A
Other languages
English (en)
Other versions
NO954146D0 (no
Inventor
Carmelita Macklin Russell
Allen I Dines
James Grigg Upson
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO954146D0 publication Critical patent/NO954146D0/no
Publication of NO954146L publication Critical patent/NO954146L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Abstract

Farmasøytisk preparat som er egnet for belegging og som omfatter et preparat for oral administrering i enhetsdoseform og hvor dette preparat er blitt belagt med fra omtrent 0,01% til omtrent 10%, uttrykt i vekt av preparatet, av en flyktig aromatisk forbindelse som er valgt fra gruppen av 3-1-men- toksypropan-l,2-diol, N-substituerte p-mentan-3-karboksamider og acykliske karboksamider og blandinger derav.
NO954146A 1993-04-30 1995-10-18 Belagte farmasöytiske preparater NO954146L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5670193A 1993-04-30 1993-04-30
PCT/US1994/004089 WO1994025009A1 (en) 1993-04-30 1994-04-13 Coated pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO954146D0 NO954146D0 (no) 1995-10-18
NO954146L true NO954146L (no) 1995-10-18

Family

ID=22006081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954146A NO954146L (no) 1993-04-30 1995-10-18 Belagte farmasöytiske preparater

Country Status (8)

Country Link
US (1) US5827852A (no)
EP (1) EP0695175A1 (no)
JP (1) JPH08509725A (no)
CN (1) CN1122103A (no)
CA (1) CA2161217A1 (no)
FI (1) FI955144A (no)
NO (1) NO954146L (no)
WO (1) WO1994025009A1 (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1655595A (en) * 1994-04-29 1995-11-09 Mcneil-Ppc, Inc. Solid pharmaceutical dosage form containing flavored film coating
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
GB9517031D0 (en) * 1995-08-19 1995-10-25 Procter & Gamble Confection compositions
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
AU3693397A (en) * 1996-07-10 1998-02-02 Novartis Consumer Health S.A. Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
ZA976189B (en) * 1996-07-12 1999-01-11 Novartis Consumer Health Sa Oral pharmaceutical combinations
WO1998024455A1 (en) * 1996-12-06 1998-06-11 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
GB9706149D0 (en) * 1997-03-25 1997-05-14 Scherer Corp R P Comestible capsules having flavoured coatings
US6564945B1 (en) * 1997-07-14 2003-05-20 Robert E. Weinstein Medication assemblage for use in sinusitis treatment regimens
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6455080B1 (en) 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
WO2001035918A1 (en) * 1999-11-15 2001-05-25 J. Manheimer, Inc. Mint flavor and aroma compositions
EA005494B1 (ru) * 2000-08-25 2005-02-24 Кова Компани, Лтд. Жидкая загрузочная композиция для капсул с ибупрофеном и препарат в виде капсул
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
FR2822709B1 (fr) * 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
EP1496752B1 (en) * 2002-04-19 2009-06-17 Wm. Wrigley Jr. Company Triple coated confectionery tablet product
US20040033257A1 (en) * 2002-05-30 2004-02-19 Strides Inc. Pharmaceutical formulation in a drug delivery system and process for preparing the same
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
EP1599100A2 (en) * 2003-03-03 2005-11-30 Wm. Wrigley Jr. Company Fast flavor release coating for confectionery
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
RU2006122662A (ru) * 2003-12-30 2008-02-10 Вм. Ригли Дж. Компани (Us) Кондитерский продукт в оболочке
PL1718164T3 (pl) * 2004-02-26 2011-03-31 Wrigley W M Jun Co Wyroby cukiernicze zawierające mieszankę fizjologicznych środków chłodzących
US20060062811A1 (en) 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP2037916A4 (en) * 2006-04-07 2011-09-14 Mike Nicolaou PURE TRITOQUALINE ISOMERS
CA2665841C (en) 2006-10-09 2016-04-05 Charleston Laboratories, Inc. Pharmaceutical compositions
WO2008100539A1 (en) * 2007-02-12 2008-08-21 Michalis Nicolaou Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, lra drugs, anti-h1 and/or anti-h2 drugs
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
CN101467988B (zh) * 2007-12-27 2014-07-09 北京德众万全医药科技有限公司 一种含有氨酚伪麻的药用组合物及其制备方法
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
KR20140097135A (ko) * 2011-09-27 2014-08-06 버지니아 커먼웰스 유니버시티 페닐에프린 및 다른 페놀계 생물활성제의 경구 생물학적 이용효능을 증가시키기 위한 선택적인 대사적 접근법
US9167830B2 (en) 2012-01-27 2015-10-27 Celanese Acetate Llc Substituted cellulose acetates and uses thereof
US9023757B2 (en) 2012-01-27 2015-05-05 Celanese Acetate Llc Substituted cellulose acetates and uses thereof
US9212290B2 (en) 2012-01-27 2015-12-15 Celanese Acetate Llc Substituted cellulose acetates and uses thereof
WO2014046679A1 (en) 2012-09-24 2014-03-27 Celanese Acetate Llc Wood laminate articles comprising substituted cellulose ester adhesives and methods relating thereto
WO2014046681A1 (en) 2012-09-24 2014-03-27 Celanese Acetate Llc Engineered wood produced with substituted cellulose ester adhesives and methods relating thereto
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
PL3639828T3 (pl) 2013-12-24 2022-05-02 Virginia Commonwealth University Zastosowanie utlenowanych siarczanów cholesterolu (ocs) w leczeniu ostrej niewydolności wątroby
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2018089797A1 (en) 2016-11-14 2018-05-17 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
GB1421743A (en) * 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
LU68016A1 (no) * 1973-07-13 1975-04-11
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
JPS61194049A (ja) * 1985-02-22 1986-08-28 Takasago Corp ｌ−メンチル３−ヒドロキシブチレ−ト，その製造法およびこれを有効成分とする冷感剤
EP0310299A1 (en) * 1987-09-28 1989-04-05 The Procter & Gamble Company Beta-amino acid ester derivatives of alcoholic actives having extended duration of activity
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
BR9205827A (pt) * 1991-04-04 1994-06-28 Procter & Gamble Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior

Also Published As

Publication number Publication date
WO1994025009A1 (en) 1994-11-10
EP0695175A1 (en) 1996-02-07
JPH08509725A (ja) 1996-10-15
FI955144A0 (fi) 1995-10-27
FI955144A (fi) 1995-10-31
NO954146D0 (no) 1995-10-18
US5827852A (en) 1998-10-27
CA2161217A1 (en) 1994-11-10
CN1122103A (zh) 1996-05-08

Similar Documents

Publication Publication Date Title
NO954146L (no) Belagte farmasöytiske preparater
NO971206D0 (no) Forlenget-frigjöringsformulering
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE156835T1 (de) Neue 11-benzaldoximestradien-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE246497T1 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
DE59610280D1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
AR018197A1 (es) Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
ATE149513T1 (de) Neue 11-benzaldoxim-17beta methoxy-17alpha- methoxymethyl-estradien-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
DE515995T1 (de) N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
FI956209A0 (fi) Hitaasti vapauttava täyteaine
DK0946585T3 (da) Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
ZA943648B (en) Medicament aerosol formulation based on fusafungine a process for its preparation and pharmaceutical compositions containing it
FI942675A0 (fi) Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
EP0523013A3 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases